Title: 12th National Scientific Congress SPML,29–31 October 2020, Online, Portugal
Abstract: Introduction:The implementation of full automation models (FAM) in the clinical laboratory allows the consolidation of chemistry and immunochemistry analyzers in the same technological solution.These solutions allow biochemical (BC) parameters and tumor markers (TM) to be processed in the same sample in a single workflow without the need for aliquots or batch processing.The mini-indexor systems (MIS) manage the traceability of samples and the electronic integration of requests from the collection areas, avoiding registration on arrival at the laboratory and a variable pre-analytical waiting time Aim: The aim of this study is to evaluate if MIS and the laboratory FAM improve patient care by delivering results in less time allowing the oncology treatments to begin earlier.Material and methods: One-week global turnaround times (TAT) were measured for the oncology unit in 3 moments: 1) before FAM, with two sample flows for both BC and TM; 2) with FAM but without MIS in petition integration, with BC and TM in a consolidated way; 3) with FAM and MIS.All petitions between 8:00 and 10:00 were considered.The mean TAT included all the parameters: albumin, LDH, K, ALT, creatinine, CA15.3,Cyfra 21.1, CEA, CA19.9 and CA125.eA2